“Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study”, Reumatismo, vol. 66, no. 3, pp. 224–232, Nov. 2014, doi: 10.4081/reumatismo.2014.748.